相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
常温,避光
- 克隆性:
单克隆
- 抗体名:
EphB4 / EPHB4 / HTK抗体
克隆号 : 04
抗体宿主 : Mouse IgG1
缓冲液 : 0.2 μm filtered solution in PBS, 5% trehalose may be added in some batches. Please read the hardcopy of COA or contact our customer service to confirm the formulation.
制备方法 : This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, human cell-derived, recombinant human EphB4 / HTK extracellular domain ( rhEphB4; Catalog#10235-H08H; NP_004435.3; Met 1-Ala 539 ). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.
EphB4 / EPHB4 / HTK抗体背景综述
EphB4, also known as Htk, Myk-1, is a member of the Eph family of receptor tyrosine kinases (RTK). The Ephs are divided into two classes based on their extracellular structure and ligand specificity, and the transmembrane receptor binding preferentially to ephrin-B ligands is referred to as EphB. Sharing common structure organization, all Eph receptors contain an N-terminal Ig-like domain, a cysteine-rich region and two fibronectin type III domains within the ECD, as well as the typical cytoplasmic tyrosine kinase domain. EphB4 and its ligand ephrin-B2 are specifically expressed on venous and arterial endothelial cells, respectively, and play an essential role in vascular development via bidirectional signals. The forward EphB4 signaling inhibits cell adhesion, chemotaxis, angiogenesis, and tumor growth. In contrast, the reverse Ephrin-B2 signaling exerts the opposite effect. It has been reported that aberrant expression of EphB4 is associated with prostate cancer and highly malignant breast cancers, and accordingly, EphB4 has potential applications as a therapeutic candidate.
EphB4 / EPHB4 / HTK抗体相关产品如下:xy-13889R CHCHD7卷曲螺旋结构域蛋白CHCHD7抗体
xy-18890R CHD1ATP依赖的解旋酶CHD1抗体
xy-18891R CHD1L染色质解旋酶DNA结合蛋白抗体
xy-13892R CHD2染色质解旋酶DNA结合蛋白2抗体
xy-18893R CHD3染色质解旋酶DNA结合蛋白3抗体
xy-13893R CHD4染色质解旋酶DNA结合蛋白Mi2β抗体
xy-13894R CHD6ATP依赖的解旋酶CHD6抗体
xy-13895R CHD7ATP依赖的解旋酶CHD7抗体
xy-13896R CHD8ATP依赖的解旋酶CHD8抗体
xy-13897R Chemokine Receptor D6趋化因子受体D6抗体
xy-13898R CHERP钙稳态内质网蛋白抗体
xy-13899R CHES1CHES1蛋白抗体
xy-13900R CHIA哺乳动物酸性几丁质酶抗体
xy-13902R CHID1几丁质酶结构域蛋白1抗体
xy-13903R Chimaerin 2嵌合蛋白2/β2-chimaerin抗体
xy-13904R CHIT1几丁质酶1抗体
xy-10093R CD97 antigen subunit alpha白细胞抗原CD97 alpha 抗体
xy-7125R Claudin 2紧密连接蛋白2抗体
xy-8482R Claudin 7紧密连接蛋白7抗体
xy-15152R C2orf53 2号染色体开放阅读框53抗体
xy-15153R C2orf542号染色体开放阅读框54抗体
xy-15154R C2orf562号染色体开放阅读框56抗体
xy-15155R C2orf612号染色体开放阅读框61抗体
xy-4763R CA153乳腺癌相关抗原抗体
xy-5113R CDCA4细胞分裂周期相关蛋白4抗体
xy-5115R Cytochrome b5细胞色素b5抗体
xy-2377R CNR2钙粘蛋白相关的神经受体2抗体
xy-15046R C1orf1861号染色体开放阅读框186抗体
xy-8871R CXCL16CXC趋化因子16抗体
xy-4878R Complement C3c alpha' chain fragment 2补体C3cα片段2抗体
xy-4874R Complement C3c alpha' chain fragment 1补体C3cα 链片段1抗体
xy-4875R Complement C3dg fragment补体C3dg片段抗体
xy-4876R Complement C3g fragment补体C3g片段抗体
xy-4877R Complement C3d fragment补体C3d片段抗体
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验人转录因子E2F1 ( E2F1 )ELISA 试剂盒 原理 本实验采用双抗体夹心 ABC-ELISA 法。用抗人 E2F1 单抗包被于酶标板上,标准品和样品中的 E2F1与单抗结合,加入生物素化的抗人 E2F1 ,形成免疫复合物连接在板上,辣根过氧化物酶标记的 Streptavidin 与生物素结合,加入底物工作液显蓝色,最后加终止液硫酸,在 450nm 处测 OD 值,E2F1 浓度与 OD 值成正比
X性联无丙种球蛋白血症(X-linked agammagl,bulinemia,XLA)是临床上首次确定的体液免疫缺陷病,由Brutor于1952年报道,故又称Bruton病。XLA作为常见的原发性免疫缺陷病之一,特点为血清中各类免疫球蛋白缺乏,或只能测得微量的抗体。外周血和淋巴组织中B细胞减少或完全缺乏,淋巴结中无生发中心和浆细胞。本病起病早,在出生数月后当患儿体内的母源性抗体水平下降时开始发病。临床表现为反复化脓性感染,患者细胞免疫功能不受影响(部分患者有T细胞数量减少),主要缺陷
ChIP是一种强大的确定蛋白或者组蛋白修饰在基因组上定位的实验方法。染色质被分离出来后采用抗体与抗原的结合来判定目的蛋白是否结合在特定的DNA序列上或者判定目的蛋白结合位点在全基因组范围的分布(微阵列或DNA序列)。这种方法具有空间性与时效性。该实验设计为如何在细胞中进行ChIP实验提供了详细的步骤。1. 交联和细胞收获甲醛可以将蛋白质交联到DNA上。交联结果的好坏决定于交联时间的把握。我们建议样品交联的时间一般为2-30分钟。过度的交联会减少抗原的结合性和超声断裂的效率。抗原决定簇也会被掩盖
技术资料暂无技术资料 索取技术资料




